Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling
Polo-like kinase 1 (PLK1) is a key cell cycle regulator implicated in the development of various cancers, including prostate cancer. However, the functions of PLK1 beyond cell cycle regulation remain poorly characterized. Here, we report that PLK1 overexpression in prostate epithelial cells triggers...
Main Authors: | Jianguo Wu, Andrei I Ivanov, Paul B Fisher, Zheng Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2016-03-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/10734 |
Similar Items
-
High throughput screening of 0.5 million compounds against CRAF using Alpha CETSAⓇ
by: Hannah Rowlands, et al.
Published: (2023-04-01) -
CRAF dimerization with ARAF regulates KRAS-driven tumor growth
by: Avinashnarayan Venkatanarayan, et al.
Published: (2022-02-01) -
Polo-like kinase in trypanosomes: an odd member out of the Polo family
by: Yasuhiro Kurasawa, et al.
Published: (2020-10-01) -
Targeting CRAF kinase in anti-cancer therapy: progress and opportunities
by: Penglei Wang, et al.
Published: (2023-12-01) -
Synthetic Strategies of Pyrimidine-Based Scaffolds as Aurora Kinase and Polo-like Kinase Inhibitors
by: Mrunal Jadhav, et al.
Published: (2021-08-01)